-
About
Overview
Corporate Culture
-
R&D
Vision & Strategy
Core Technologies
IP & Licensing
R&D Collaboration
Trials & Results
-
Solutions
Cell Therapy
GTP Center
-
Investors
- News Center
- Contact
-
Hotline
- 中
BioRay Professional Service Team
We’re here to help! Please choose the service you need.：
Customer Service Hotline
Have questions about health supplements or daily skincare?
0800-200-026Testing Inquiry
Want to learn more or book your personalized test?
06-505-2755ODM/OEM
Looking for Health Supplement ODM/OEM Partnerships?
08-762-6868Service Hours: Monday – Friday, 8:30 AM – 5:30 PM
News
2022.12.15
賀！國軍總院與光晟合作之CIK細胞治療第四期實體癌已通過衛福部核可
光晟生技「自體免疫細胞(CIK)」治療實體癌施行計畫，獲衛福部核准與「國軍高雄總醫院附設民眾診療服務處」施行計畫，除了嘉惠癌友也象徵與在地國軍醫院合作的緊密關係。
2022年12月8日起核准通過內容，適應症為實體癌第四期之肺癌、肝癌、乳癌、卵巢癌、大腸直腸癌、頭頸癌、胃癌、腎癌；光晟生技將提供專業的「自體免疫細胞(CIK)」治療技術，為癌友謀求新選擇。